Paradigm shift has been determined from traditional culture identification to speedy respiratory disease identification – a game-changer within the respiratory disease medicine market. within the ancient technique, cultures square measure wont to find respiratory disease conducive organisms. this can be a long method with a better error rate in comparison to speedy medicine. during a few cases like Legionella pneumophilia, culture identification isn’t without delay offered and this will increase the deathrate of pneumonia cases caused by it. The speedy rate of technological advancement has created pneumonia identification a lot of faster and more cost effective with a larger degree of sensitivity and specificity. The urinary matter is an extremely-effective rapid test that enables targeted therapy foe legionnaire at the point-of-care itself.
The Pneumonia Diagnostics Market has been segmented as below:
By Product:
By Regional Analysis:
The Pneumonia Diagnostics Market is segmented on the lines of its product and regional. Basis of Product is segmented into Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based and Mycoplasma Pneumonia-based. The Pneumonia Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Pneumonia Diagnostics Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Pneumonia Diagnostics Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Pneumonia Diagnostics Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Thermo Fisher Scientific Inc., Alere Inc., Quidel Corporation, Becton, Dickinson and Company and Meridian Bioscience, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Pneumonia Diagnostics Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Pneumonia Diagnostics Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Drug of Abuse (DOA) Testing Market
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Report Summary
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restrains
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Pneumonia Diagnostics Market Analysis, By Product
5.1 Streptococcus based
5.2 Legionella based
5.3 Chlamydophila based
5.4 Mycoplasma Pneumonia based
5.5 Viral Pneumonia based
6. Pneumonia Diagnostics Market Analysis, By Region
6.1 North America
6.2 Europe
6.3 Asia-Pacific
6.4 Rest of the World
7. Competitive Overview
7.1 Introduction
7.2 New Product Launches
7.3 Acquisitions
7.4 Agreements, Partnerships, And Collaborations
7.5 Expansions
8. Company Profiles
8.1 Thermo Fisher Scientific Inc.
8.2 Quidel Corporation
8.3 Alere Inc.
8.4 Meridian Bioscience, Inc.
8.5 Becton, Dickinson and Company
8.6 bioMérieux SA
8.7 Bio-Rad Laboratories Inc.
8.8 Cardinal Health Inc.
8.9 Qiagen N.V.
8.10 Beckman Coulter Inc (Danaher Corporation)
The Pneumonia Diagnostics Market has been segmented as below:
By Product:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
